|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
(3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one |
International Nonproprietary Names ![]() |
|
INN number | INN |
8004 | semaxanib |
Synonyms ![]() |
SU 5416 | SU5416 | VEGF receptor 2 kinase inhibitor III |
Comments |
Semaxanib was a precursor in the development of the next generation kinase inhibitor ultimately approved as sunitinib. |
Database Links ![]() |
|
CAS Registry No. | 194413-58-6 |
ChEMBL Ligand | CHEMBL276711 |
GtoPdb PubChem SID | 178101750 |
PubChem CID | 5329098 |
RCSB PDB Ligand | X2M |
Search Google for chemical match using the InChIKey | WUWDLXZGHZSWQZ-WQLSENKSSA-N |
Search Google for chemicals with the same backbone | WUWDLXZGHZSWQZ |
Search PubMed clinical trials | semaxanib |
Search PubMed titles | semaxanib |
Search PubMed titles/abstracts | semaxanib |
Search UniChem for chemical match using the InChIKey | WUWDLXZGHZSWQZ-WQLSENKSSA-N |
Search UniChem for chemicals with the same backbone | WUWDLXZGHZSWQZ |
Wikipedia | Semaxanib |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
SU 5416
Cat. No. 3037 |